Implementation deadlines

IMPLEMENTATION SCHEDULE

 

 

  • June 2016 : For new marketing authorization

​​​

 

  • December 2017 : For products already marketed

 

 

 

CURRENT REGULATION

The ICH Q3D guideline comes into effect in the three pharmacopeias (Europe, US and Japan).                                                                                                                                                                                                             

USP -232- ELEMENTAL IMPURITIES LIMITS 
USP -233- ELEMENTAL IMPURITIES PROCEDURES

JP 1.07 "HEAVY METALS LIMIT TEST"
PH. EUR: 5.20, 2.4.20, 2.4.8

 

 

 

To fullfill ICH Q3D requirements before this deadlines expired, we develop Elemental Impurities Implementation of Risk Assessment Reports, for both API manufacturers and drug product manufacturers. You can contact us regarding a QUOTATION REQUEST for an ICH Q3D report development.

Latest news

B4B Connection - Tox innovation & New trends

Socosur Tox services will of course attend next B4B Connection focused on Innovation and New Trends...(...)

Dedicated A3P event - Cleaning validation

Since September 2016, A3P working group "Cleaning Validation" has been working on Annex 15...(...)

Indian deal confirmed Socosur - Azierta con Exim local support

Alberto Carazo confirms agreement has been reached with Socosur together with Exim for the...(...)

CPhI 2017

Socosur Chem is exhibiting again on Indis Associates (of which Exim Corp.) botth 80F02. An...(...)

Stay in touch